Fundraising FoxAnuncia Medical
Scottsdale, US · Founded 2018 · Delaware corporation · 3 known investors
Find your way into Anuncia Medical
Sign up to see every warm intro you have to Anuncia Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Anuncia Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Anuncia Medical develops medical technology focused on cerebrospinal fluid (CSF) science and clinical strategy to advance hydrocephalus treatment. The company combines decades of medtech expertise to serve the hydrocephalus care market.
Founders & leadership
DB
Darryl BakerExecutive
EA
Elsa AbruzzoExecutiveElsa Abruzzo is a medical device executive with 33+ years of experience in product development, regulatory affairs, and clinical strategy. She co-founded Anuncia Medical and previously founded Cygnus Regulatory, a regulatory consulting firm, while holding leadership roles at companies including Baxter, Cordis (Johnson & Johnson), CryoLife, Percutaneous Valve Technologies, AtriCure, and Sapheon. She holds a B.S. in engineering from the University of Miami and is a Regulatory Affairs Certified (RAC) professional and RAPS Fellow.
Board
DD
ED
Edgar D JanottaBoard director
SR
Stanton RoweBoard director
SO
Stephen OesterleBoard director
PA
PJ AnandBoard director
GK
Ghassan KassabBoard director
RU
Richard UptonBoard director
Investors · 3
Arieal Southeast Angel Partnerslisted by Arieal Southeast Angel PartnersSavannah · $100K – $2M
How we know: Arieal Southeast Angel Partners's portfolio page · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$17.7M disclosed across 3 rounds · 2021–2024
▶$13.9MraisedNov 2025 · 87 investors · BiotechnologyRule 506(b)
▶$13.9MraisedNov 2025 · 87 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stanton RoweDirector
- Darryl BakerExecutive Officer
- Elsa AbruzzoExecutive Officer, Director
- Stephen OesterleDirector
- PJ AnandDirector
- Ghassan KassabDirector
- Richard UptonDirector
- David DonabedianDirector
- Edgar D JanottaDirector
- Offering amount
- $16.4M
- Amount sold
- $13.9M
- Finders' fees
- $66.5K
- Proceeds to insiders
- $450K
- Placement agents
- U.S. Boston Capital Corporation
- First sale
- Aug 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.4MraisedApr 2024 · 28 investors · BiotechnologyRule 506(b)
▶$3.4MraisedApr 2024 · 28 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ghassan KassabDirector
- Elsa AbruzzoExecutive Officer, Director
- PJ AnandDirector
- Stanton RoweDirector
- David DonabedianDirector
- Edgar D JanottaDirector
- Stephen OesterleDirector
- Richard UptonDirector
- Offering amount
- $4M
- Amount sold
- $3.4M
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$427.5KraisedDec 2021 · 7 investors · BiotechnologyRule 506(b)
▶$427.5KraisedDec 2021 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stanton RoweDirector
- Stephen OesterleDirector
- Edgar D JanottaDirector
- David DonabedianDirector
- Richard UptonDirector
- PJ AnandDirector
- Elsa AbruzzoExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $427.5K
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 5
Encore MedicalEncore Medical develops cardiovascular medical devices, with clinical work focused on patent foramen ovale (PFO) and related conditions such as migraine. It operates in the cardiovascular medical device sector.
CqmedicalCQ Medical develops patient positioning and immobilization products used in radiation therapy, including devices for brachytherapy, SBRT, SRS, and proton treatments. Its offerings serve oncology and radiotherapy clinicians treating cancer and conditions such as osteoarthritis.
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Innova VascularInnova Vascular is a medical device company focused on the vascular space, led by a founder with a background in developing and commercializing vascular medical devices. The page provides limited detail about the company's specific products.
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Companies working in the same space as Anuncia Medical.
In the news
Frequently asked questions
- What does Anuncia Medical do?
- Anuncia Medical develops medical technology focused on cerebrospinal fluid (CSF) science and clinical strategy to advance hydrocephalus treatment. The company combines decades of medtech expertise to serve the hydrocephalus care market.
- Who are Anuncia Medical's investors?
- Anuncia Medical's investors include Arieal Southeast Angel Partners, Xcellerant Ventures, Longwood Fund.
- How much funding has Anuncia Medical raised?
- Anuncia Medical has disclosed $17.7M raised across 3 rounds.
- Where is Anuncia Medical headquartered?
- Anuncia Medical is headquartered in Scottsdale, US.